Drug Sensitisation

  • J. R. Gibson
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 87 / 2)

Abstract

The study of drug sensitisation embraces a number of scientific disciplines and is relevant to virtually every branch of medical practice. It has been estimated that 5% of medical hospital admissions are due to adverse drug reactions and that among hospital in-patients 15% suffer from an ill effect due to drugs (Parker 1975). It should be noted that many such unwanted occurrences are due to relative or absolute overdosing, side effects, secondary effects, drug interactions, intolerance and idiosyncrasy (DeSwarte 1980), but nonetheless drug allergy occurs in a significant number of patients and represents a considerable problem.

Keywords

Aspirin Penicillin Histamine Anhydride Macromolecule 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ackroyd JF (1975) Immunological mechanisms in drug hypersensitivity. In: Gell PHG, Coombs RRA, Lachmann PJ (eds) Clinical aspects of immunology, 3rd edn. Blackwell, Oxford, pp 913–961Google Scholar
  2. Adkinson NF, Thompson WL, Maddrey WC, Lichtenstein LM (1971) Routine use of penicillin skin testing on an inpatient service. N Engl J Med 285:22–24PubMedCrossRefGoogle Scholar
  3. Agrup G (1972) Patch testing in drug allergy. In: Dash CH, Jones HEH (eds) Mechanisms in drug allergy. Churchill Livingstone, Edinburgh, pp 135–138Google Scholar
  4. Amos HE (1976) Allergic drug reactions. Arnold, LondonGoogle Scholar
  5. Arndt KA, Jick H (1976) Rates of cutaneous reactions to drugs. JAMA 235:918–923PubMedCrossRefGoogle Scholar
  6. Asherson GL, Perera MACC, Thomas WR (1979) Contact sensitivity and the DNA response in mice to high and low doses of oxazolone: low dose unresponsiveness following painting and feeding and its prevention by pretreatment with cyclophosphamide. Immunology 36:449–459PubMedGoogle Scholar
  7. Assem ESK (1972 a) The passive sensitization of human lung as a test for drug allergy. In: Dash CH, Jones HEH (eds) Mechanisms in drug allergy. Churchill Livingstone, Edinburgh, pp 112–120Google Scholar
  8. Assem ESK (1972 b) IgE and other in vitro tests in the diagnosis and follow-up of drug allergy. In: Dash CH, Jones HEH (eds) Mechanisms in drug allergy. Churchill Livingstone, Edinburgh, pp 179–188Google Scholar
  9. Assem ESK (1977) Tests for detecting drug allergy. In: Davies DM (ed) Textbook of adverse drug reactions. Oxford University Press, New York, pp 397–410Google Scholar
  10. Barna BP, Gogate P, Deodhar SD, Moeder M (1980) Lymphocyte transformation and radioallergosorbent tests in drug hypersensitivity. Am J Clin Pathol 73:172–176PubMedGoogle Scholar
  11. Bendixen G, Soborg M (1969) A leucocyte migration technique for in vitro detection of cellular (delayed type) hypersensitivity in man. Dan Med Bull 16:1–6PubMedGoogle Scholar
  12. Bigby M, Jick S, Jick H, Arndt K (1986) Drug-induced cutaneous reactions: a report from the Boston collaborative drug surveillance program on 15438 consecutive inpatients, 1975 to 1982. JAMA 256:3358–3363PubMedCrossRefGoogle Scholar
  13. Brostoff J (1972) The leucocyte migration tests in drug allergy. In: Dash CH, Jones HEH (eds) Mechanisms in drug allergy. Churchill Livingstone, Edinburgh, pp 177–178Google Scholar
  14. Bruinsma W (1977) A guide to drug eruptions. Krips Repro, Meppel, The NetherlandsGoogle Scholar
  15. Chase MW (1946) Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp Biol Med 61:257–259PubMedGoogle Scholar
  16. Coombs RRA, Gell PGH (1975) Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Gell PGH, Coombs RRA, Lachmann PJ (eds) Clinical aspects of immunology, 3rd edn. Blackwell, Oxford, pp 761–781Google Scholar
  17. DeSwarte RD (1980) Drug allergy. In: Patterson R (ed) Allergic diseases — diagnosis and management, 2nd edn. Lippincott, Philadelphia, pp 452–583Google Scholar
  18. de Weck AL (1971) Immunological effects of aspirin anhydride, a contaminant of commercial acetylsalicylic acid preparations. Int Arch Allergy 41:393–418PubMedCrossRefGoogle Scholar
  19. de Weck AL (1979) Approaches to prevention and treatment of drug allergy. In: Turk JL, Parker D (eds) Drugs and immune responsiveness. Macmillan, London, pp 211–221Google Scholar
  20. de Weck AL, Schneider CH (1972) Specific inhibition of allergic reactions to penicillin in man by a monovalent hapten. Int Arch Allergy 42:782–797PubMedCrossRefGoogle Scholar
  21. Dobozy A, Hunyadi J, Kenderessy ASZ, Simon N (1981) Lymphocyte transformation test in detection of drug hypersensitivity. Clin Exp Dermatol 6:367–372PubMedCrossRefGoogle Scholar
  22. Eisen HN (1959) Hypersensitivity to simple chemicals. In: Lawrence HS (ed) Cellular and humoral aspects of the hypersensitive states. Hoeber-Harper, New York, pp 89–122Google Scholar
  23. Eisner EV, Shahidi NT (1972) Immune thrombocytopenia due to a drug metabolite. N Engl J Med 287:376–381PubMedCrossRefGoogle Scholar
  24. Ekelund AG, Moller H (1969) Oral provocation in eczematous contact allergy to neomycin and hydroxy-quinolines. Acta Derm Venereol (Stockh) 49:422–426Google Scholar
  25. Epstein JH (1977) Photocontact allergy in humans. In: Marzulli FN, Maibach HI (eds) Dermatotoxicology and pharmacology. Hemisphere, Washington, pp 413–426Google Scholar
  26. Fisher AA (1973) Contact dermatitis, 2nd edn. Lea and Febiger, PhiladelphiaGoogle Scholar
  27. Gigli I (1982) Immunological aspects of skin diseases. In: Lachmann PJ, Peters DK (eds) Clinical aspects of immunology, 4th edn. Blackwell, Oxford, pp 790–821Google Scholar
  28. Girard JP, Cattin S, Cuevas M (1976) Immunological mechanisms and diagnostic tests in allergic drug reactions. Ann Clin Res 8:74–84PubMedGoogle Scholar
  29. Gower RG, Sams WM, Thorne EG, Kohler PF, Claman HN (1977) Leukocytoclastic vasculitis: sequential appearance of immunoreactants and cellular changes in serial biopsies. J Invest Dermatol 69:477–484PubMedCrossRefGoogle Scholar
  30. Greaves MW (1980) Pharmacological factors in initiation of cutaneous vasculitis. In: Wolff K, Winkelmann RK (eds) Vasculitis. Lloyd-Luke (Medical Books), London, pp 49–53Google Scholar
  31. Harber LC, Baer RL (1972) Pathogenic mechanisms of drug-induced photosensitivity. J Invest Dermatol 58:327–342PubMedCrossRefGoogle Scholar
  32. Henson PM (1982) Antibody and immune-complex-mediated allergic and inflammatory reactions. In: Lachmann PJ, Peters DK (eds) Clinical aspects of immunology, 4th edn. Blackwell, Oxford, pp 687–709Google Scholar
  33. Hindsen M, Christensen OB, Gruic V, Lofberg H (1987) Fixed drug eruption: an immunohistochemical investigation of the acute and healing phase. Br J Dermatol 116: 351– 360PubMedCrossRefGoogle Scholar
  34. Hjorth N (1977) Diagnostic patch testing. In: Marzulli FN, Maibach HI (eds) Dermatotoxicology and pharmacology. Hemisphere, Washington, pp 341–351Google Scholar
  35. Hjorth N, Fregert S (1979) Contact dermatitis. In: Rook A, Wilkinson DS, Ebling FJG (eds) Textbook of dermatology, vol 1, 3rd edn. Blackwell, Oxford, pp 363–441Google Scholar
  36. Jegasothy BV (1983) Immune complexes in cutaneous disease. Arch Dermatol 119:795–798PubMedCrossRefGoogle Scholar
  37. Juhlin L, Wide L (1972) IgE antibodies and penicillin allergy. In: Dash CH, Jones HEH (eds) Mechanisms in drug allergy. Churchill Livingstone, Edinburgh, pp 139–147Google Scholar
  38. Kauppinen K, Stubb S (1984) Drug eruptions: causative agents and clinical types. Acta Derm Venereol (Stockh) 64:320–324Google Scholar
  39. Kligman AM (1966) The identification of contact allergens by human assay. J Invest Dermatol 47:375–392PubMedGoogle Scholar
  40. Kligman AM, Epstein WL (1959) Some factors affecting contact sensitization in man. In: Shaffer JH, Logrippo GA, Chase MW (eds) Mechanisms of hypersensitivity. Churchill Livingstone, London, pp 713–722Google Scholar
  41. Kristofferson A, Ahlstedt S, Enander I (1982) Contact sensitivity in guinea pigs to different penicillins. Int Arch Allergy Appl Immunol 69:316–321PubMedCrossRefGoogle Scholar
  42. Kuokkanen K (1972) Drug eruptions. Acta Allergol 27:407–438PubMedGoogle Scholar
  43. Lakin JD, Grace WR, Sell KW (1975) IgE antipolymyxin B antibody formation in a T-cell-depleted bone marrow transplant patient. J Allergy Clin Immunol 56:94–103PubMedCrossRefGoogle Scholar
  44. Lemanske RF, Kaliner MA (1983) Late phase allergic reactions. Int J Dermatol 22:401–409PubMedCrossRefGoogle Scholar
  45. Lever WF, Schaumburg-Lever G (1983) Eruptions due to drugs. In: Histopathology of the skin, 6th edn. Lippincott, Philadelphia, pp 259–270Google Scholar
  46. Levine BB (1966) Immunochemical mechanisms of drug allergy. Annu Rev Med 17:23–38PubMedCrossRefGoogle Scholar
  47. Levine BB, Zolov DM (1969) Prediction of penicillin allergy by immunological tests. J Allergy 43:231–244PubMedCrossRefGoogle Scholar
  48. Ling NR (1972) Lymphocyte transformation in drug allergy. In: Dash CH, Jones HEH (eds) Mechanisms in drug allergy. Churchill Livingstone, Edingburgh, pp 171–175Google Scholar
  49. Macher E, Chase MW (1969) Studies on the sensitization of animals with simple chemical compounds. J Exp Med 129:103–121PubMedCrossRefGoogle Scholar
  50. Moneret-Vautrin DA, Grilliat JP, Pupil P (1972) Basophil degranulation in drug allergy. In: Dash CH, Jones HEH (eds) Mechanisms in drug allergy. Churchill Livingstone, Edinburgh, pp 159–170Google Scholar
  51. Murphy GF, Guillen FJ, Flynn TC (1985) Cytotoxic T lymphocytes and phenotypically abnormal epidermal dendritic cells in fixed cutaneous eruptions. Hum Pathol 16(12):1264–1271PubMedCrossRefGoogle Scholar
  52. Odom RB, Maibach HI (1977) Contact urticaria: a different contact dermatitis. In: Marzulli FN, Maibach HI (eds) Dermatotoxicology and pharmacology. Hemisphere, Washington, pp 441–453Google Scholar
  53. Parish WE (1986) Clinical immunology and allergy. In: Rook A, Wilkinson DS, Ebling FJG, Champion RH, Burton JL (eds) Textbook of dermatology, vol 1, 4th edn. Black-well, Oxford, pp 309–353Google Scholar
  54. Parker CW (1972) Practical aspects of diagnosis and treatment of patients who are hypersensitive to drugs. In: Samter M, Parker CW (eds) International encyclopedia of pharmacology and therapeutics, section 75, vol I, Hypersensitivity to drugs, 1st edn. Pergamon Oxford, pp 367–394Google Scholar
  55. Parker CW (1975) Drug therapy, drug allergy, (first of three parts). N Engl J Med 292:511–514PubMedCrossRefGoogle Scholar
  56. Parker D, Long PV, Turk JL (1983) A comparison of the conjugation of DNTB and other dinitrobenzenes with free protein radicals and their ability to sensitize or tolerize. J Invest Dermatol 81:198–201PubMedCrossRefGoogle Scholar
  57. Pence HL, Evans R (1972) In vitro methods of detecting drug hypersensitivity. Med Ann DC 41:431–436PubMedGoogle Scholar
  58. Polak L (1977) Immunological aspects of contact sensitivity. In: Marzulli FN, Maibach HI (eds) Dermatotoxicology and pharmacology. Hemisphere, Washington, pp 225–288Google Scholar
  59. Roupe G, Strannegard O (1969) Anaphylactic shock elicited by topical administration of bacitracin. Arch Dermatol 100:450–452PubMedCrossRefGoogle Scholar
  60. Schneider CH (1970) Immunochemistry of penicillin. In: Stewart GT, McGovern JP (eds) Penicillin allergy. Thomas, Springfield IL, pp 23–58Google Scholar
  61. Sehgal VN, Gangwani OP (1987) Fixed drug eruption: current concepts. Int J Dermatol 26:67–74PubMedCrossRefGoogle Scholar
  62. Siraganian RP (1983) Histamine secretion from mast cells and basophils. Trends Pharmacol Sci 4:432–437CrossRefGoogle Scholar
  63. Soter NA (1980) Cutaneous necrotizing venulitis. In: Wolff K, Winkelmann RK (eds) Vasculitis. Lloyd-Luke (Medical Books), London, pp 173–182Google Scholar
  64. Soter NA (1983) Mast cells in cutaneous inflammatory disorders. J Invest Dermatol 80(6 Suppl):22s–25sCrossRefGoogle Scholar
  65. Soter NA, Austen KF (1980) Biology of the mast cell and its products and of the complement system. In: Wolff K, Winkelmann RK (eds) Vasculitis. Lloyd-Luke (Medical Books), London, pp 54–67Google Scholar
  66. Spath P, Huber H, Ludvan M, Roth A, Schwarz S, Zeiger J (1979) Determinations of penicilloyl specific IgE antibodies for the evaluation of hypersensitivity against penicillin. Allergy 34:405–411PubMedCrossRefGoogle Scholar
  67. Spry CJF (1980) Eosinophilia and allergic reactions to drugs. Clin Haematol 9:521–534PubMedGoogle Scholar
  68. Streilein JW (1983) Skin-associated lymphoid tissues (SALT): origins and functions. J Invest Dermatol 80(6 Suppl):12s–16sPubMedCrossRefGoogle Scholar
  69. Suzuki S, Asai Y, Hamada T, Mizoguchi Y, Yamada T, Morisawa S (1978) Drug-induced lymphocyte transformation in peripheral lymphocytes from patients with drug eruptions. Dermatologica 157:146–153PubMedCrossRefGoogle Scholar
  70. Tagami H, Tatsuta K, Iwatski K, Yamada M (1983) Delayed hypersensitivity in ampicillin-induced toxic epidermal necrolysis. Arch Dermatol 119:910–913PubMedCrossRefGoogle Scholar
  71. Thomas R, Edwards AJ, Watkins MC, Asherson GL (1980) Distribution of immunogenic cells after painting with the contact sensitizers fluorescein isothiocyanate and oxazolone. Different sensitizers form immunogenic complexes with different cell populations. Immunology 39:21–27PubMedGoogle Scholar
  72. Van Arsdel PP (1978) Adverse drug reactions. In: Middleton E (ed) Allergy: principles and practice, vol 2. Mosby Year Book, London, pp 1133–1158Google Scholar
  73. Van Joost T, Tank B, Stolz E, Habets JMW (1987) Causative agents and pathogenicity in iatrogenic cutaneous autoimmunity. Int J Dermatol 26:75–79PubMedCrossRefGoogle Scholar
  74. Willis I, Kligman AM (1968) The mechanism of photoallergic contact dermatitis. J Invest Dermatol 51:378–384PubMedGoogle Scholar
  75. Wintroub BU, Stern RS, Arndt KA (1987) Cutaneous reactions to drugs. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (eds) Dermatology in general medicine, 3rd edn. McGraw-Hill, New York, pp 1353–1366Google Scholar
  76. Witte KW, West DP (1982) Immunology of adverse drug reactions. Pharmacotherapy 2:54–65PubMedGoogle Scholar
  77. Wolff K, Stingl G (1983) The Langerhans cell. J Invest Dermatol 80(6 Suppl):17s–21sCrossRefGoogle Scholar
  78. Woosley RL, Drayer DE, Reidenberg MM, Nies AS, Carr K, Oates JA (1978) Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med 298:1157–1159PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • J. R. Gibson

There are no affiliations available

Personalised recommendations